Care for bipolar disorder in LMICs needs evidence from local settings

The Lancet Psychiatry

Volumn 2, Issue 9, 2015, Pages 772-773

  Fekadu, Abebaw ^a,b   Hanlon, Charlotte ^a,b   Thornicroft, Graham ^b   Lund, Crick ^c   Kaaya, Sylvia ^d   Alem, Atalay ^a   Gureje, Oye ^e   Cleare, Anthony J ^b   Patel, Vikram ^f,g,h   Prince, Martin J ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g Sangath   (India)

^h PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; LOWEST INCOME GROUP; MENTAL DISEASE; MENTAL HEALTH SERVICE; NOTE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; TREATMENT PLANNING; ECONOMICS; EVIDENCE BASED PRACTICE; HEALTH SERVICE; PRIMARY HEALTH CARE;

BIPOLAR DISORDER; DEVELOPING COUNTRIES; EVIDENCE-BASED PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PRIMARY HEALTH CARE;

EID: 84940750133     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00222-9     Document Type: Note

References (11)

1. Merikangas KR, Jin R, He J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011, 68:241-251.
2. Fekadu A, Kebede D, Alem A, et al. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira, Ethiopia. Acta Psychiatr Scand 2006, 114:426-434.
3. mhGAP intervention guide for mental, neurological and substance use disorders in non-specialised health settings 2010, WHO, World Health Organization, Geneva, (accessed July 28, 2015). http://whqlibdoc.who.int/publications/2010/9789241548069_eng.pdf.
4. Cookson J Use of antipsychotic drugs and lithium in mania. Br J Psychiatry 2001, 178(suppl 41):s148-s156.
5. Littlejohn R, Leslie F, Cookson J Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiatry 1994, 165:827-829.
6. Fox NJ Practice-based evidence: towards collaborative and transgressive research. Sociology 2003, 37:81-102.
7. Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003, 160:1263-1271.
8. Henry MVC, Etain B, Gehue LJ, et al. An evidence map of psychosocial interventions for the earliest stages of bipolar disorders. Lancet Psychiatry 2015, 2:548-563.
9. Miklowitz DJ Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry 2008, 165:1408-1419.
10. Patel V, Weiss HA, Chowdhary N, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet 2010, 376:2086-2095.
11. Rahman A, Malik A, Sikander S, Roberts C, Creed F Cognitive behaviour therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomised controlled trial. Lancet 2008, 372:902-909.